Anthera Announces Fourth Quarter 2011 Financial Report and Conference Call
HAYWARD, Calif., Feb. 9, 2012 /PRNewswire/ – Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, will release its fourth quarter 2011 financial report before the market opens on…